| Dr Vaishnavi N Reddy, MD | |
|
2520 B F Terry Blvd, Rosenberg, TX 77471-5636 | |
| (281) 342-6006 | |
| (281) 239-7554 |
| Full Name | Dr Vaishnavi N Reddy |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 30 Years |
| Location | 2520 B F Terry Blvd, Rosenberg, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336103217 | NPI | - | NPPES |
| 160018957 | Other | TX | RAILROAD GBA - RAILROAD MEDICARE |
| 8DE544 | Other | TX | BC/BS # |
| 87885J | Other | TX | BC/BS TX# |
| P01090539 | Other | TX | RAILROAD MEDICARE PTAN |
| 045822602 | Medicaid | TX | |
| 045822601 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | K6912 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Texas Home Health Skilled Services | Wharton, TX | Home health agency |
| Texas Home Health Skilled Services | Sugar land, TX | Home health agency |
| Memorial Hermann Sugar Land Hospital | Sugar land, TX | Hospital |
| Oakbend Medical Center | Richmond, TX | Hospital |
| Memorial Hermann Hospital System | Houston, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Memorial Hermann Medical Group | 7012008360 | 590 |
News Archive
Using some of the most advanced molecular sequencing tools available to evaluate COVID-19 rapid autopsy tissues, researchers have identified four major regulatory pathways, specific molecular effectors behind COVID-19 symptoms, and differences that drive diverging clinical courses among individual patients.
Peregrine Pharmaceuticals, Inc. today announced that it has established a new Anti-Viral Research Group in its R&D organization.
A group of tiny RNA that should attack the virus causing COVID-19 when it tries to infect the body are diminished with age and chronic health problems, a decrease that likely helps explain why older individuals and those with preexisting medical conditions are vulnerable populations, investigators report.
Palatin Technologies, Inc. today announced that the last patient has completed treatment in its Phase 2B clinical trial evaluating the efficacy and safety of bremelanotide for treatment of female sexual dysfunction (FSD).
› Verified 7 days ago
| Entity Name | Memorial Hermann Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003985102 PECOS PAC ID: 7012008360 Enrollment ID: O20070801000368 |
News Archive
Using some of the most advanced molecular sequencing tools available to evaluate COVID-19 rapid autopsy tissues, researchers have identified four major regulatory pathways, specific molecular effectors behind COVID-19 symptoms, and differences that drive diverging clinical courses among individual patients.
Peregrine Pharmaceuticals, Inc. today announced that it has established a new Anti-Viral Research Group in its R&D organization.
A group of tiny RNA that should attack the virus causing COVID-19 when it tries to infect the body are diminished with age and chronic health problems, a decrease that likely helps explain why older individuals and those with preexisting medical conditions are vulnerable populations, investigators report.
Palatin Technologies, Inc. today announced that the last patient has completed treatment in its Phase 2B clinical trial evaluating the efficacy and safety of bremelanotide for treatment of female sexual dysfunction (FSD).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Vaishnavi N Reddy, MD 2100 Regional Medical Dr, Wharton, TX 77488-9719 Ph: (979) 532-1700 | Dr Vaishnavi N Reddy, MD 2520 B F Terry Blvd, Rosenberg, TX 77471-5636 Ph: (281) 342-6006 |
News Archive
Using some of the most advanced molecular sequencing tools available to evaluate COVID-19 rapid autopsy tissues, researchers have identified four major regulatory pathways, specific molecular effectors behind COVID-19 symptoms, and differences that drive diverging clinical courses among individual patients.
Peregrine Pharmaceuticals, Inc. today announced that it has established a new Anti-Viral Research Group in its R&D organization.
A group of tiny RNA that should attack the virus causing COVID-19 when it tries to infect the body are diminished with age and chronic health problems, a decrease that likely helps explain why older individuals and those with preexisting medical conditions are vulnerable populations, investigators report.
Palatin Technologies, Inc. today announced that the last patient has completed treatment in its Phase 2B clinical trial evaluating the efficacy and safety of bremelanotide for treatment of female sexual dysfunction (FSD).
› Verified 7 days ago
Megha Singh, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2520 B F Terry Blvd, Rosenberg, TX 77471 Phone: 281-342-6006 | |
Dr. Quratulain Hayat, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5115 Avenue H Ste 701, Rosenberg, TX 77471 Phone: 713-486-1950 Fax: 713-486-0858 | |
Dr. Letosha Evette Gale, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 7607 Town Center Blvd, Rosenberg, TX 77471 Phone: 281-344-0207 Fax: 281-239-0114 | |
Shelia Denise Briscoe, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1229 Corporate Dr, Rosenberg, TX 77471 Phone: 281-342-3400 Fax: 281-342-3404 | |
Khalid Mahmood Chaudhary, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1217 1st St, Rosenberg, TX 77471 Phone: 281-342-8761 Fax: 281-232-7492 | |
Dr. Khin Hla Aung, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2520 B F Terry Blvd, Rosenberg, TX 77471 Phone: 281-342-6006 Fax: 281-239-7554 |